Dishman Pharmaceuticals & Chemicals | DISHMAN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2015
2016
2017
2018
Revenue
Revenue
15,88715,96117,13716,948
Cost of revenue
Cost of revenue
-5,495-3,363-3,293-3,369
Gross Profit
Gross Profit
10,393
12,598
13,844
13,579
Sales, general & ad...
Sales, general and administrative
-7,266-8,494-9,310-9,125
Depreciation
Depreciation and amortization
-1,507-1,091-2,135-2,114
Provision
Provision
0000
Other op inc/exp...
Other operating income/expenses
0000
Operating income
Operating income EBIT
1,620
3,013
2,399
2,339
 
     
Profit before tax
Profit before tax
1,5922,3342,1702,308
Net Income
Net income
1,198
1,711
1,454
1,546
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
7.42
10.60
9.01
9.58